Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces.

Using ellipsometry, anodized tantalum interference color, and Coomassie blue staining in conjunction with immunologic identification of proteins adsorbed at interfaces, we have previously found that fibrinogen is the main constituent deposited by plasma onto many man-made surfaces. However, the fibrinogen deposited from normal plasma onto glass and similar wettable materials is rapidly modified during contact activation until it can no longer be identified antigenically. In earlier publications, we have called this modification of the fibrinogen layer "conversion," to indicate a process of unknown nature. Conversion of adsorbed fibrinogen by the plasma was not accompanied by marked change in film thickness, so that we presumed that this fibrinogen was not covered but replaced by other protein. Conversion is now showen to be markedly delayed in plasma lacking high molecular weight kininogen, slightly delayed in plasma lacking factor XII, and normal in plasma that lack factor XI or prekallikrein. We conclude that intact plasma will quickly replace the fibrinogen it has deposited on glass-like surfaces by high molecular weight kininogen and, to a smaller extent, by factor XII. Platelets adhere preferentially to fibrinogen-coated surfaces; human platelets adhere to hydrophobic nonactivating surfaces, since on these, adsorbed firbinogen is not exchanged by the plasma. The adsorbed fibrinogen will be replaced on glass-like surfaces during surface activation of clotting, and platelets failing to find fibrinogen will not adhere.

[1]  A. L. Adams,et al.  Identification of rapid changes at plasma-solid interfaces. , 1969, Journal of biomedical materials research.

[2]  L. Vroman,et al.  Platelet Adhesion Induced by Fibrinogen Adsorbed onto Glass∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  L. Vroman,et al.  Findings with the recording ellipsometer suggesting rapid exchange of specific plasma proteins at liquid/solid interfaces☆ , 1969 .

[4]  L. Vroman,et al.  REACTIONS OF FORMED ELEMENTS OF BLOOD WITH PLASMA PROTEINS AT INTERFACES * , 1977 .

[5]  L. Vroman,et al.  What factors determine thrombogenicity. , 1972, Bulletin of the New York Academy of Medicine.

[6]  K. Ackles Blood-Bubble Interaction in Decompression Sickness. , 1973 .

[7]  L. Vroman,et al.  Possible Involvement of Fibrinogen and Proteolysis in Surface Activation , 1967, Thrombosis and Haemostasis.

[8]  R. Colman,et al.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. , 1975, The Journal of clinical investigation.

[9]  O. Ratnoff,et al.  Evidence that Fitzgerald factor counteracts inhibition by kaolin or ellagic acid of the amidolytic properties of a plasma kallikrein. , 1976, Blood.

[10]  A. Lukoševičius,et al.  Ellipsometer Recordings of Changes in Optical Thickness of Adsorbed Films associated with Surface Activation of Blood Clotting , 1964, Nature.

[11]  R. Waldmann,et al.  Fitzgerald Trait DEFICIENCY OF A HITHERTO UNRECOGNIZED AGENT , FITZGERALD FACTOR , PARTICIPATING IN SURFACE-MEDIATED REACTIONS OF CLOTTING , FIBRINOLYSIS , GENERATION OF KININS , AND THE PROPERTY OF DILUTED PLASMA ENHANCING VASCULAR PERMEABILITY ( PF / DIL ) , 2022 .

[12]  J. Griffin,et al.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. , 1977, Proceedings of the National Academy of Sciences of the United States of America.